The FDA fails American patients again and again

Michael Cannon writes,

Again and again, the FDA fails American patients. Last week, the United Kingdom approved a new antiviral pill (molnupiravir). Studies show the drug reduces the risk of hospitalization and death among high-risk COVID patients by half. U.S. taxpayers funded molnupiravir’s development. Yet the U.S. Food and Drug Administration isn’t even meeting to consider approval until Nov. 30.

Read the whole thing here: https://www.nydailynews.com/opinion/ny-oped-fda-fails-american-patients-20211109-d2zzig2ounflbgczympfwrtp3u-story.html